Cargando...
Application of molecular targeted therapies in the treatment of head and neck squamous cell carcinoma
Despite the development of standard therapies, including surgery, radiotherapy and chemotherapy, survival rates for head and neck squamous cell carcinoma (HNSCC) have not changed significantly over the past three decades. Complete recovery is achieved in <50% of patients. The treatment of advance...
Gardado en:
| Publicado en: | Oncol Lett |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
D.A. Spandidos
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5920345/ https://ncbi.nlm.nih.gov/pubmed/29725456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.8300 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|